Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02092428 · ClinicalTrials.gov registry record · Phase 1
Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)
A Phase 1 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 333
- Enrollment target
NCT02092428 is a Phase 1 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 333 participants.
The verdict
NCT02092428, a Phase 1 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 333 participants
- Enrollment target
Study Summary
Investigators at the Biomedical Imaging Research Institute (BIRI) at Cedars-Sinai Medical Center have developed a Magnetic Resonance Imaging (MRI) method for imaging coronary arteries using slow-infusion, contrast-enhanced data acquisition. This method allows faster data acquisition and better spatial resolution. Specific aims of this study are to: 1. compare coronary artery imaging with and without contrast media on both healthy subjects and patients; 2. assess the accuracy of coronary MRI in detecting coronary artery disease as compared to conventional x-ray angiography Researchers hypothesize that contrast-enhanced MRI will improve the delineation of coronary arteries over non-contrast-enhanced MRI and that optimized, contrast-enhanced coronary MRI technique will accurately detect coronary artery disease (CAD) as compared to conventional x-ray angiography.
Interventions
- OTHER Image Quality
- OTHER Diagnostic Accuracy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2011-04 |
| Est. Completion | 2017-03-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02092428
The ClinicalTrials.gov registry entry for NCT02092428 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Image Quality is the first listed.
NCT02092428 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02092428 about?
NCT02092428 is a clinical study titled "Contrast- Enhanced Whole-Heart Coronary MRA at 3.0T (Tesla)". Investigators at the Biomedical Imaging Research Institute (BIRI) at Cedars-Sinai Medical Center have developed a Magnetic Resonance Imaging (MRI) method for imaging coronary arteries using slow-infusion, contrast-enhanced data acquisition. This method allows faster data acquisition and better spati...
What is the current status of trial NCT02092428?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 333 participants. The study started on 2011-04. Estimated completion is 2017-03-01.
What interventions are being tested in trial NCT02092428?
The interventions under investigation include: Image Quality (OTHER), Diagnostic Accuracy (OTHER).
Who is sponsoring clinical trial NCT02092428?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.